Cardiovascular Devices Global Market Report 2018 Including: Cardiovascular Surgery Devices; Cardiac Rhythm Management (CRM) Devices; Interventional Cardiology Devices; Defibrillator Devices; Peripheral Vascular Devices; Prosthetic Heart Valve Device; Electrophysiology Devices; Cardiac Assist Devices Covering: Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences
Feb 2018
Reasons to Purchase • Outperform competitors using accurate up to date demand-side dynamics information. • Identify growth segments for investment. • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market. • Create regional and country strategies on the basis of local data and analysis. • Stay abreast of the latest customer and market research findings • Benchmark performance against key competitors. • Develop strategies based on likely future developments. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Gain a global perspective on the development of the market. • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Scope Markets Covered: Cardiovascular Surgery Devices; Cardiac Rhythm Management (CRM) Devices; Interventional Cardiology Devices; Defibrillator Devices; Peripheral Vascular Devices; Prosthetic Heart Valve Device; Electrophysiology Devices; Cardiac Assist Devices Companies Mentioned: Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia. Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa Time series: Five years historic and forecast. Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, Cardiovascular Devices Indicators Comparison. Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments. Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Cardiovascular Devices Market Characteristics Cardiovascular devices are designed to diagnose, prevent, monitor and treat diseases related to the cardiovascular system Including heart diseases and related health problems. They include arrhythmia detectors, noninvasive blood pressure measurement systems, diagnostic intravascular catheters, external cardiac compressors, coronary vascular physiologic simulation software devices, external programmable pacemaker pulse generators, cardiac monitors, cardiopulmonary bypass defoamers, echocardiographs, vascular graft prostheses, electrocardiographs, defibrillators and others. The cardiovascular devices market in this report is segmented into cardiovascular surgery devices, cardiac rhythm management (CRM) devices, interventional cardiology devices, defibrillator devices, peripheral vascular devices, prosthetic heart valve device, electrophysiology devices and cardiac assist devices Cardiovascular Surgery Devices Cardiovascular surgery devices are used in Cardiac Rhythm Management (CRM) Devices These devices are used to manage the heart rate or Interventional Cardiology Devices Interventional cardiology devices are used in Defibrillator Devices Defibrillator Devices are used in the Peripheral Vascular Devices Peripheral vascular devices are used to
Prosthetic Heart Valve Devices Electrophysiology Devices are used in the diagnosis and treatment of Cardiac Assist Devices are artificial mechanic pumps that assist the heart in
In this report market value is defined as the revenues organizations earn by selling their goods and services within the specified market, based on the price at which they sell. Only goods and services traded between entities are included. The revenues for a specified geography are consumption values – that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced.
Cardiovascular Devices Market Historic Growth The global cardiovascular devices market grew from $X billion in 2013 to $X billion in 2017 at a compound annual growth rate (CAGR) of X%. The chart and table below shows the year-on-year growth of the global cardiovascular devices market during 2013 – 2017.
Drivers of the Market:
Restraints on the Market:
Cardiovascular Devices Market Forecast Growth The global cardiovascular devices market is expected to grow from $XX billion in 2017 to $61.4 billion in 2021 at a compound annual growth rate (CAGR) of XX%. The chart and table below shows the year-on-year growth of the global cardiovascular devices market during 2017 - 2021.
Drivers of the Market:
Restraints on the Market:
Cardiovascular Devices Market Segmentation The chart and table below shows the split of the cardiovascular devices market in 2017.
The total market value for cardiovascular devices was $X billion in 2017. The markets that are covered include Cardiovascular Surgery Devices; Cardiac Rhythm Management (CRM) Devices; Interventional Cardiology Devices; Defibrillator Devices; Peripheral Vascular Devices; Prosthetic Heart Valve Device; Electrophysiology Devices; Cardiac Assist Devices.
Cardiovascular Surgery Devices was the X largest segment in the cardiovascular devices market with X% share of the market. The market value for the cardiovascular surgery devices was $X billion in 2017. Cardiac Rhythm Management (CRM) Devices made up around X% share of the market. The market value for the cardiac rhythm management (CRM) Devices was $X billion in 2017.
Cardiovascular Devices Market Regional And Country Analysis The Asia Pacific was the largest region in the cardiovascular devices market in 2017, cardiovascular devices for $X billion or X% market share. North America was the x largest region cardiovascular devices for $X billion or X% market share. Western Europe was the x largest region cardiovascular devices for $X billion or X% market share.
Cardiovascular Devices Market Competitive Landscape The leading competitors in the global cardiovascular devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences. The chart and table below displays the percentage market share of the top players in the cardiovascular devices market industry.
Medtronic plc generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Abbott Laboratories generated revenues of $XX billion for the financial year 2016, an XX% decrease from the previous year. Boston Scientific Corporation generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Cardinal Health, Inc. generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year.
Edwards Lifesciences generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Terumo Corporation generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. B. Braun Holding GmbH & Co. KG generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year. Johnson & Johnson Inc. generated revenues of $XX billion for the financial year 2016, an XX% decrease from the previous year. C.R. Bard, Inc. (U.S.) generated revenues of $XX billion for the financial year 2016, an XX% increase from the previous year.
Company Profile Medtronic plc Overview Medtronic was the largest company in the cardiovascular devices market in 2017, with an XX% share of the market. It is a medical technology, services and solutions company and serves hospitals, physicians, clinicians and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is headquartered in Dublin, Ireland. Products and Services The company operates through the following divisionsThe Cardiac and Vascular group caters to The Minimally Invasive Technologies Group provides The Restorative Therapies group provides The Diabetes Group consists of
Strategy Medtronic’s growth strategy is to capture untapped business opportunities in emerging markets through acquisitions. For instance, In January 2015, Medtronic acquired Covidien Plc for $49.9 Billion in cash. This deal gives Medtronic the Covidien’s portfolio of cardiac and vascular devices, Financial Performance Medtronic’s cardiac and vascular group division involved in the cardiovascular devices manufacturing, generated revenues of $XX billion for the financial year 2017, a XX% increase from the previous year. The company had a market Abbott Laboratories Overview Products and Services Strategy Financial Performance
Boston Scientific Corporation Overview Products and Services Strategy Financial Performance
Cardinal Health Inc. Overview Products and Services Strategy Financial Performance
Edwards Lifesciences Overview Products and Services Strategy Financial Performance